Simultaneously improving the activity and thermostability of a new proline 4-hydroxylase by loop grafting and site-directed mutagenesis

trans -Proline 4-hydroxylases ( trans -P4Hs) hydroxylate free L-proline to trans -4-hydroxy-L-proline ( trans -4-Hyp) is a valuable chiral synthon for important pharmaceuticals such as carbapenem antibiotics. However, merely few microbial trans -P4Hs have been identified, and trans -4-Hyp fermentati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied microbiology and biotechnology 2019-01, Vol.103 (1), p.265-277
Hauptverfasser: Liu, Chao, Zhao, Jing, Liu, Jiao, Guo, Xuan, Rao, Deming, Liu, Haiping, Zheng, Ping, Sun, Jibin, Ma, Yanhe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:trans -Proline 4-hydroxylases ( trans -P4Hs) hydroxylate free L-proline to trans -4-hydroxy-L-proline ( trans -4-Hyp) is a valuable chiral synthon for important pharmaceuticals such as carbapenem antibiotics. However, merely few microbial trans -P4Hs have been identified, and trans -4-Hyp fermentations using engineered Escherichia coli strains expressing trans -P4Hs are usually performed at temperatures below 37 °C, which is likely due to poor stability and low activities. In the present study, a new trans -P4H from uncultured bacterium esnapd13 (UbP4H) with potential in the fermentative production of trans -4-Hyp at 37 °C was reported. In order to enhance the activity and thermostability of UbP4H, the replacement of its putative “lid” loop in combination with site-directed mutagenesis was performed. Consequently, four loop hybrids were designed by substituting a loop of UbP4H (A162-K178) with the corresponding sequences of four other known trans -P4Hs, respectively. Among them, UbP4H-Da exhibited a doubled activity when compared to the wild type (81.6 ± 1.9 vs. 40.4 ± 4.6 U/mg) but with reduced thermostability ( t 1/2 , 11 vs. 47 min). Meanwhile, 10 single variants were designed through sequence alignments and folding free energy calculations. Three best point substitutions were respectively combined with UbP4H-Da, resulting in UbP4H-Da-R90G, UbP4H-Da-E112P, and UbP4H-Da-A260P. UbP4H-Da-E112P exhibited a 1.8-fold higher activity (85.2 ± 0.6 vs. 46.6 ± 4.0 U/mg), a 7.6-fold increase in t 1/2 (359 vs. 47 min), and a 3 °C rise in T m (46 vs. 43 °C) when compared to UbP4H. The fed-batch fermentations of trans -4-Hyp at 37 °C using trans -4-Hyp producing chassis cells expressing UbP4H or its variants were evaluated, and a 3.3-fold increase in trans -4-Hyp titer was obtained for UbP4H-Da-E112P (12.9 ± 0.1 vs. 3.9 ± 0.0 g/L for UbP4H). These results demonstrate the potential application of UbP4H-Da-E112P in the industrial production of trans -4-Hyp.
ISSN:0175-7598
1432-0614
DOI:10.1007/s00253-018-9410-x